Ronan O'Hagan
11Patents
3h-index
28Co-inventors
56Inventor score
Filing activity: Aug 27, 2004 → Dec 28, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11053294B2 | Masked cytokine polypeptides | Chemistry; Metallurgy | 11 | Active |
| US7544476B1 | Identifying cancers sensitive to treatment with inhibitors of notch signaling | Chemistry; Metallurgy | 8 | Active |
| US9879083B2 | Anti-Notch3 antibodies | Chemistry; Metallurgy | 8 | Active |
| US10745476B2 | Anti-NOTCH3 antibodies | Chemistry; Metallurgy | 3 | Active |
| US12269877B2 | Anti-notch3 antibodies | Chemistry; Metallurgy | 0 | Active |
| US11866476B2 | Masked IL-2-Fc fusion polypeptides | Chemistry; Metallurgy | 0 | Active |
| US11827685B2 | Masked cytokine polypeptides | Chemistry; Metallurgy | 0 | Active |
| US11718655B2 | Masked interleukin-12 polypeptides | Chemistry; Metallurgy | 0 | Active |
| US11827686B2 | Masked cytokine polypeptides | Chemistry; Metallurgy | 0 | Active |
| US7622630B2 | Chimeric cancer models | Chemistry; Metallurgy | 0 | Expired |
| US7556796B2 | Directed complementation | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.